Difficulty: Medium
Average Score: 80%
Practice
A 54-year-old man with diabetes presents to clinic for a routine checkup. At his prior two visits, he had an elevated blood pressure and has tried lifestyle changes to improve it. Today, his blood pressure is 142/88 mm Hg. His last urinalysis showed a urine microalbumin of 150 mcg. What is the most appropriate initial antihypertensive for this patient?
Correct answer
C
Rationale
The most appropriate initial antihypertensive for the 54-year-old man with diabetes and elevated blood pressure of 142/88 mm Hg and microalbuminuria of 150 mcg is option C, Lisinopril. Lisinopril, an ACE inhibitor, is recommended as the first-line agent for patients with diabetes and hypertension due to its renal protective effects and cardiovascular benefits. It helps to reduce proteinuria and slow the progression of diabetic nephropathy, making it an ideal choice in this scenario.
Option A, Doxazosin, is an alpha-blocker and not generally recommended as a first-line agent for hypertension in patients with diabetes. Option B, Hydrochlorothiazide, a thiazide diuretic, may exacerbate microalbuminuria and is not the preferred initial choice in this patient population. Option D, Metoprolol, a beta-blocker, is also not the preferred initial agent in patients with diabetes as it may mask hypoglycemia symptoms.
Educationally, understanding the rationale behind selecting antihypertensive medications based on comorbidities like diabetes and associated complications such as microalbuminuria is crucial for healthcare providers to provide optimal patient care and improve outcomes in this high-risk population. It is essential to consider not only blood pressure control but also the overall cardiovascular and renal protective effects of the chosen antihypertensive medication.
Option A, Doxazosin, is an alpha-blocker and not generally recommended as a first-line agent for hypertension in patients with diabetes. Option B, Hydrochlorothiazide, a thiazide diuretic, may exacerbate microalbuminuria and is not the preferred initial choice in this patient population. Option D, Metoprolol, a beta-blocker, is also not the preferred initial agent in patients with diabetes as it may mask hypoglycemia symptoms.
Educationally, understanding the rationale behind selecting antihypertensive medications based on comorbidities like diabetes and associated complications such as microalbuminuria is crucial for healthcare providers to provide optimal patient care and improve outcomes in this high-risk population. It is essential to consider not only blood pressure control but also the overall cardiovascular and renal protective effects of the chosen antihypertensive medication.